Status:
RECRUITING
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Lead Sponsor:
Biotronik SE & Co. KG
Conditions:
Tachycardia
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This registry is performed for the long-term assessment of outcome, performance and residual safety aspects of the BIOMONITOR III and possible successors in a real-life clinical set-up. In addition, t...
Eligibility Criteria
Inclusion
- Patient is intended to receive a BIOTRONIK Implantable Cardiac Monitor (ICM)
- Patient is able to understand the nature of the registry and to provide written informed consent.
- Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept.
Exclusion
- Patient is pregnant or breast feeding.
- Patient is less than 18 years old.
- Patient is participating in another interventional clinical investigation other than the submodules of BIO\|STREAM.ICM
Key Trial Info
Start Date :
October 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2027
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT04075084
Start Date
October 28 2019
End Date
August 30 2027
Last Update
October 1 2025
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Integral Health
Adelaide, Australia
2
Royal Adelaide Hospital
Adelaide, Australia
3
Nemocnice Ceske Budejovice, a.s.
České Budějovice, Czechia, 37001
4
Hôpital Saint-André
Bordeaux, France